• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ribociclib-induced Vitiligo: a Case Report.

作者信息

Silvestre Torner Nicolás, Aguilar Martínez Antonio, Echarri González María José, Tabbara Carrascosa Sergio, Román Sainz Jorge, Gruber Velasco Fernando

机构信息

Department of Dermatology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain.

Department of Oncology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain.

出版信息

Dermatol Pract Concept. 2022 Apr 1;12(2):e2022045. doi: 10.5826/dpc.1202a45. eCollection 2022 May.

DOI:10.5826/dpc.1202a45
PMID:35646430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9116537/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/9116537/72014e6927b5/dp1202a45g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/9116537/dc5acc7ec472/dp1202a45g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/9116537/72014e6927b5/dp1202a45g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/9116537/dc5acc7ec472/dp1202a45g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/9116537/72014e6927b5/dp1202a45g002.jpg

相似文献

1
Ribociclib-induced Vitiligo: a Case Report.瑞博西尼诱发的白癜风：一例报告
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022045. doi: 10.5826/dpc.1202a45. eCollection 2022 May.
2
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review.一例接受细胞周期蛋白依赖性激酶（CDK）4/6抑制剂治疗的转移性乳腺癌患者出现白癜风样皮损：病例报告及文献综述
Clin Cosmet Investig Dermatol. 2022 Jan 5;15:5-10. doi: 10.2147/CCID.S344867. eCollection 2022.
3
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.乳腺癌中环磷酰胺依赖性激酶 4/6 抑制剂相关毒性和药物相互作用的临床处理：实用注意事项和建议。
Oncologist. 2017 Sep;22(9):1039-1048. doi: 10.1634/theoncologist.2017-0142. Epub 2017 Jul 13.
4
Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis.比较不同细胞周期蛋白依赖性激酶 4/6 抑制剂在转移性乳腺癌中的治疗相关不良事件：一项网络荟萃分析。
Cancer Treat Rev. 2020 Nov;90:102086. doi: 10.1016/j.ctrv.2020.102086. Epub 2020 Aug 17.
5
Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.来曲唑与阿那曲唑治疗绝经后激素受体阳性、人表皮生长因子受体 2 阴性晚期乳腺癌的疗效和安全性的 Meta 分析
Expert Rev Anticancer Ther. 2018 Mar;18(3):201-213. doi: 10.1080/14737140.2018.1435275. Epub 2018 Feb 19.
6
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.接受 CDK4/6 抑制剂治疗的晚期乳腺癌患者出现白癜风样病变。
Breast Cancer Res Treat. 2021 Jan;185(1):247-253. doi: 10.1007/s10549-020-05914-w. Epub 2020 Sep 10.
7
Ribociclib induced acute kidney injury: A case report.利波西利导致的急性肾损伤：一例报告。
J Oncol Pharm Pract. 2021 Dec;27(8):2023-2026. doi: 10.1177/10781552211007202. Epub 2021 Apr 13.
8
A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.用于治疗转移性乳腺癌的细胞周期蛋白依赖性激酶抑制剂的最新全面综述。
Curr Med Res Opin. 2017 Sep;33(9):1559-1569. doi: 10.1080/03007995.2017.1348344. Epub 2017 Jul 25.
9
Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib.细胞周期蛋白依赖性激酶 4/6 抑制剂在乳腺癌中的应用：帕博西尼、瑞博西尼和阿贝西利。
Breast Cancer Res Treat. 2017 Nov;166(1):41-54. doi: 10.1007/s10549-017-4385-3. Epub 2017 Jul 24.
10
Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications.帕博西尼和瑞博西尼在乳腺癌中的不同心脏毒性：基因表达和药物数据分析、生物学基础及治疗意义。
BioDrugs. 2019 Dec;33(6):613-620. doi: 10.1007/s40259-019-00382-1.

引用本文的文献

1
Vitiligo-Like Depigmentation Induced by Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Metastatic Breast Cancer: A Case Report and Literature Review.细胞周期蛋白依赖性激酶4/6抑制剂治疗转移性乳腺癌所致白癜风样色素脱失：1例报告及文献复习
Cureus. 2025 May 5;17(5):e83513. doi: 10.7759/cureus.83513. eCollection 2025 May.
2
A Vitiligo-like Cutaneous Reaction Induced by Ribociclib in Advanced Breast Cancer: An Unusual Case Report from Colombia.瑞博西尼诱发的晚期乳腺癌白癜风样皮肤反应：来自哥伦比亚的一例罕见病例报告
Diseases. 2025 May 19;13(5):158. doi: 10.3390/diseases13050158.
3
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors.

本文引用的文献

1
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.接受 CDK4/6 抑制剂治疗的晚期乳腺癌患者出现白癜风样病变。
Breast Cancer Res Treat. 2021 Jan;185(1):247-253. doi: 10.1007/s10549-020-05914-w. Epub 2020 Sep 10.
2
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients.来曲唑联合或不联合瑞博西利治疗激素受体阳性、人表皮生长因子受体 2 阴性晚期或转移性乳腺癌患者的随机、开放性、III 期研究 （仅供参考，实际译文以最终确认为准）
Ann Pharmacother. 2019 May;53(5):501-509. doi: 10.1177/1060028018817904. Epub 2018 Dec 7.
对接受细胞周期蛋白依赖性激酶4和6抑制剂治疗的乳腺癌患者中白癜风样病变的多中心回顾性研究。
Breast Cancer Res Treat. 2024 Apr;204(3):643-647. doi: 10.1007/s10549-023-07217-2. Epub 2024 Jan 15.
4
Case Report: Ribociclib-induced phototoxicity presented as dyschromia with subsequent bullae formation.病例报告：瑞博西尼引起的光毒性表现为色素沉着异常，随后形成大疱。
Front Oncol. 2023 Aug 24;13:1184738. doi: 10.3389/fonc.2023.1184738. eCollection 2023.
5
Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review.帕博西尼诱导的细胞周期蛋白依赖性激酶 4/6 抑制剂相关类白癜风样皮损：一例病例报告及文献复习。
Pathol Oncol Res. 2023 Jul 6;29:1611115. doi: 10.3389/pore.2023.1611115. eCollection 2023.